Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Recruiting

Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia

NCT06537843

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Hospital Ophir Loyola Belém, Brazil
  • Hospital de Clínicas da UFPR Curitiba, Brazil
  • Hospital Universitario Polydoro Ernani de Sao Thiago Florianópolis, Brazil
  • Hospital Amaral Carvalho Jaú, Brazil
View Trial Details
Recruiting

Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

NCT06532058

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
  • The First People's Hospital of Changzhou Changzhou, Jiangsu, China
  • Huai 'an First People's Hospital Huaian, Jiangsu, China
View Trial Details
Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

NCT05546580

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine

NCT06263387

Conditions
AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Amiens CHU Amiens, France
  • Angers CHU Angers, France
  • Avignon CH Avignon, France
  • Bayonne CH Bayonne, France
View all 42 locations
View Trial Details

Related conditions